Vexxa Lifesciences Pvt. Ltd. — Oxaliplatin Exporter Profile
Indian Pharmaceutical Exporter · #15 for Oxaliplatin · $408.3K export value · DGFT Verified
Vexxa Lifesciences Pvt. Ltd. is the #15 Indian exporter of Oxaliplatin with $408.3K in export value and 84 verified shipments. Vexxa Lifesciences Pvt. Ltd. holds a 0.9% market share in Oxaliplatin exports across 2 countries.
Vexxa Lifesciences Pvt. Ltd. — Oxaliplatin Export Profile: Buyers & Destinations
Where Does Vexxa Lifesciences Pvt. Ltd. Export Oxaliplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $397.6K | 81 | 78.6% |
| MYANMAR | $108.5K | 26 | 21.4% |
Vexxa Lifesciences Pvt. Ltd. exports Oxaliplatin to 2 countries. The largest destination is PHILIPPINES accounting for 78.6% of Vexxa Lifesciences Pvt. Ltd.'s Oxaliplatin shipments. These destinations reflect Vexxa Lifesciences Pvt. Ltd.'s established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Oxaliplatin from Vexxa Lifesciences Pvt. Ltd.?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| VE PHARMA INC | PHILIPPINES | $238.6K | 49 |
| VE PHARMA INC. | PHILIPPINES | $159.0K | 32 |
| ASHRO MYANMAR LIMITED | MYANMAR | $108.5K | 26 |
Vexxa Lifesciences Pvt. Ltd. supplies Oxaliplatin to 3 buyers globally. The largest buyer is VE PHARMA INC (PHILIPPINES), followed by VE PHARMA INC. (PHILIPPINES) and ASHRO MYANMAR LIMITED (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Oxaliplatin Export Value and How Much Does Vexxa Lifesciences Pvt. Ltd. Contribute?
India exported $32.6M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. Vexxa Lifesciences Pvt. Ltd. contributes $408.3K to this total, accounting for 0.9% of India's Oxaliplatin exports. Vexxa Lifesciences Pvt. Ltd. ships Oxaliplatin to 2 countries through 3 buyers.
What Is the Average Shipment Value for Vexxa Lifesciences Pvt. Ltd.'s Oxaliplatin Exports?
Vexxa Lifesciences Pvt. Ltd.'s average Oxaliplatin shipment value is $4.9K per consignment, based on 84 shipments totaling $408.3K. The largest destination is PHILIPPINES (78.6% of Vexxa Lifesciences Pvt. Ltd.'s Oxaliplatin exports).
How Does Vexxa Lifesciences Pvt. Ltd. Compare to Other Indian Oxaliplatin Exporters?
Vexxa Lifesciences Pvt. Ltd. ranks #15 among 249 Indian Oxaliplatin exporters with a 0.9% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($16.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.6M), ACCURE LABS PRIVATE LIMITED ($2.6M). Vexxa Lifesciences Pvt. Ltd. processed 84 shipments to 2 destination countries.
What Oxaliplatin Formulations Does Vexxa Lifesciences Pvt. Ltd. Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Vexplatin 50 (OXALIPLATIN INJECTION BP ( | $110.1K | 24 |
| Vexplatin 100 (OXALIPLATIN INJ 100 MG) | $61.7K | 12 |
| Vexplatin 50 Inj (OXALIPLATIN INJECTIONBP (50MG/25ML) BATCH NO-OXIB25A04-A MFGDT-FEB-2025 EXP DT-JAN-2027 | $52.1K | 4 |
| VEXPLATIN 50 INJ (OXALIPLATIN INJECTION | $42.4K | 6 |
| Vexplatin 100 OXALIPLATIN INJ 100 MG BCH NO-OXIH23B36-A MANUFACTURING DT-AUG-2023 EXP DT-JUL-2025 | $21.2K | 4 |
| Vexplatin 100 (OXALIPLATIN INJ 100 MG) B | $20.3K | 4 |
| VEXPLATIN 100 (OXALIPLATIN INJECTION 100 | $18.1K | 2 |
| Vexplatin VE 50 Inj (OXALIPLATIN Inj 50MG) BATCH NO-X4LOX013B MFG DT-DEC-2024 EXP DT-NOV-2026 | $13.0K | 4 |
| VEXPLATIN VE 50 INJ (OXALIPLATIN INJ 50MG) BCH NO-X3LOX083C MFG DT-DEC-2023 NOV-2025 | $11.9K | 1 |
| Vexplatin 50 OXALIPLATIN INJECTION BP 50MG/25ML BCH NO-OXIH23A23-A MANUFACTURING DT-AUG-2023 EXP DT-JUL-2025 | $11.5K | 2 |
Vexxa Lifesciences Pvt. Ltd. exports 40 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Vexplatin 50 (OXALIPLATIN INJECTION BP ( with 24 shipments worth $110.1K.
How Does Vexxa Lifesciences Pvt. Ltd. Compare to Nearest Oxaliplatin Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MYLAN LABORATORIES LIMITED | $600.0K | 12 | 1 | $50.0K |
| 14 | CELON LABORATORIES PRIVATE LIMITED | $558.4K | 46 | 14 | $12.1K |
| 15 | VEXXA LIFESCIENCES PVT. LTD. ★ | $408.3K | 84 | 2 | $4.9K |
| 13 | JODAS EXPOIM PVT LTD | $200.0K | 4 | 1 | $50.0K |
| 12 | DR.REDDY'S LABORATORIES LTD | $150.0K | 3 | 1 | $50.0K |
Vexxa Lifesciences Pvt. Ltd. ranks #15 among 249 Indian Oxaliplatin exporters. Average shipment value of $4.9K compared to the market average of $130.9K. The closest competitors by value are MYLAN LABORATORIES LIMITED and CELON LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Oxaliplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 535 | 17.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 453 | 14.7% |
| DELHI AIR | 436 | 14.2% |
| SAHAR AIR | 410 | 13.3% |
| CHAWAPAYAL ICD (INCPR6) | 110 | 3.6% |
| Bombay Air | 108 | 3.5% |
| NHAVA SHEVA SEA (INNSA1) | 97 | 3.1% |
| CHAWAPAYAL ICD | 95 | 3.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vexxa Lifesciences Pvt. Ltd. matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 107 individual customs records matching Vexxa Lifesciences Pvt. Ltd. exporting Oxaliplatin, covering 40 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Export Data from Vexxa Lifesciences Pvt. Ltd.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vexxa Lifesciences Pvt. Ltd.'s Oxaliplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vexxa Lifesciences Pvt. Ltd.
Company Profile
0 products · $0 total trade · 0 categories
Oxaliplatin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vexxa Lifesciences Pvt. Ltd..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current shipment-level data, contact TransData Nexus.